High Purity Dolutegravir Intermediate CAS 1229006-21-6

Product Details
Customization: Available
Powder: Yes
Customized: Non-Customized
Still deciding? Get samples of $ !
Request Sample
Manufacturer/Factory, Trading Company
Gold Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Years of Export Experience
The export experience of the supplier is more than 10 years
Experienced Team
The supplier has 8 foreign trading staff(s) and 8 staff(s) with over 6 years of overseas trading experience
Exhibition Experience
The supplier had participated in offline trade shows, you can check the Audit Report for more information
to see all verified strength labels (13)
  • High Purity Dolutegravir Intermediate CAS 1229006-21-6
  • High Purity Dolutegravir Intermediate CAS 1229006-21-6
  • High Purity Dolutegravir Intermediate CAS 1229006-21-6
  • High Purity Dolutegravir Intermediate CAS 1229006-21-6
  • High Purity Dolutegravir Intermediate CAS 1229006-21-6
  • High Purity Dolutegravir Intermediate CAS 1229006-21-6
Find Similar Products
  • Overview
  • Product Parameters
  • Product Description
  • Detailed Photos
  • Company Profile
  • Certifications
  • Exhibition
  • Packaging & Shipping
Overview

Basic Info.

Model NO.
Dolutegravir Intermediate CAS 1229006-21-6
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Children, Adult
State
Solid
Purity
>99%
Transport Package
Bag, Drum
Specification
99% min
Trademark
Hanways
Origin
China
Production Capacity
5 Tons Per Month

Product Description

High Purity Dolutegravir Intermediate CAS 1229006-21-6
Factory Supply Dolutegravir Intermediate CAS 1246616-66-9
 
Product Parameters
Name Dolutegravir Intermediate
CAS 1229006-21-6
MF C26H26F2N2O7
MW 516.49
EINECS 1592732-453-0
Appearance White powder
Categories Intermediate;HIV-1 integrase inhibitor;Pharmaceutical
Uses Dolutegravir has been approved for treating a broad population of HIV-infected patients, including adults undergoing their first treatment as well as those who have been treated with other integrase transfer strand inhibiting agents.
Product Description
 
Dolutegravir has been approved for treating a broad population of HIV-infected patients, including adults undergoing their first treatment as well as those who have been treated with other integrase transfer strand inhibiting agents.
Detailed Photos

High Purity Dolutegravir Intermediate CAS 1229006-21-6

Company Profile

High Purity Dolutegravir Intermediate CAS 1229006-21-6High Purity Dolutegravir Intermediate CAS 1229006-21-6

Certifications

High Purity Dolutegravir Intermediate CAS 1229006-21-6

Exhibition

 

High Purity Dolutegravir Intermediate CAS 1229006-21-6
Packaging & Shipping

 

High Purity Dolutegravir Intermediate CAS 1229006-21-6

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier